Menu

Vaccine Virtual Days health professional sitting with stethoscope around neck

Vaccine Virtual Days 2022

Let science guide the way

Vaccine Virtual Days is an annual GSK-sponsored virtual congress event that invites Health Care Professionals (HCPs) and External Experts (EEs) from around the world to learn more about key Immunology topics. Historically the event has featured presentations from Immunology experts, physicians, and opinion leaders, sharing their points of view, data, and developments in the field of Immunology. Vaccine Virtual Days 2022 was the first specialized edition of this event, featuring a range of topics on the value and growing importance of Adult Immunization. An Independent Scientific Committee was identified to design agenda topics & help identify speakers for each of the sessions.

Vaccine Virtual Days 2022 took place on March 30th and 31st 2022 and provided a unique opportunity for HCPs and EEs to connect with and learn from the global vaccine community.

Here are a few key highlights and statistics:

  • 43 internationally recognized speakers discussing the value and importance of adult immunization
  • Over 5000 active attendees across more than 140 countries
  • 95% of attendees agree that the event would help them make a more informed decision benefiting patient care

Watch Vaccine Virtual Days 2022 session recordings

The COVID-19 booster debate: where do we stand today?

Breaking news: forgotten issues in vaccines and the concept of One Health

Engaging the immunisation neighbourhood – all hands on deck

Immunisation of older adults – Part 1: Life course immunisation program and immunosenescence

Immunisation of older adults – Part 2: Improving vaccine responses and the role of vaccines in combating antimicrobial resistance

Generating momentum around the world to implement adult immunisation

Vaccines questions on your mind: Ask the expert

The agenda topics were selected by an independent Scientific Committee of international experts

Jane Barrat

CANADA

Jane Barratt

Secretary General, International Federation on Ageing Member, Vision Academy, Director, Baycrest Health Sciences, CSO Rep. WHO COVAX Pillar vaccine strategy

Paolo Bonnani

Italy

Paolo Bonanni

Professor of Hygiene and Public Health Sciences, Director of the Department of Health Sciences, University of Florence

Stefania Maggi

Italy

Stefania Maggi

Director of research c/o National Research Council, Neuroscience Institute-Aging Branch Padua, Italy

Jean-Pierre Michel

Switzerland

Jean-Pierre Michel

Professor of Geriatric Medicine and Honorary professor of Medicine, Geneva University – Switzerland, Member of the French and Spanish Academy of Medicine 

John Oppenheimer

USA

John Oppenheimer

Director of Clinical Research at Pulmonary and Allergy Associates, Clinical Professor of Medicine at UMDNJ – Rutgers

Rosana Richtmann

Brazil

Rosana Richtmann

Infectious Disease Physician from Emílio Ribas Institute, Director of the Immunization Committee from the Brazilian Society of Infectious Disease, PhD by Freiburg University, Germany

Mich Rothholz

USA

Mitchel Rothholz

Chief of Governance & State Affiliates and Executive Director, APhA Foundation, American Pharmacists Association

Mary Slack

UK

Mary Slack

Independent Consultant at Mary Slack Microbiology Consulting Ltd, Professor at Griffith University School of Medicine, Australia

LJ Tan

USA

LJ Tan

Chief Strategy Officer, Immunize.org, Co-Chair, National Adult and Influenza Immunization Summit

Key points from Vaccine Virtual Days 2022

Stefania Maggi VVD3

“We need to have a proactive attitude toward increasing the knowledge in general population among the healthcare practionners”

Stefania Maggi, during “Breaking news: forgotten issues in vaccines and the concept of One Health” session

George Griffin VVD3

“[...] In terms of the older population we are now becoming aware that vaccination is also so very important in healthcare. Population of this age group over 65 will more than double before 2050 a huge number of people will be in this population and they will be be subjeted to infection."

George Griffin, during “Immunisation of older adults – Part 1: Life course immunisation program and immunosenescence” session

Abby Bownas VVD3

"I think having the pandemic has shown us what some of the gaps were in terms of where people were getting access and I think certainly equity is one of those.."

Abby Bownas, during “Generating momentum around the world to implement adult immunization” session

Jane Barratt VVD3

"It's not about young versus old, or middle age, it's about this life-course implementation"

Jane Barratt, during “Vaccines questions on your mind: Ask the expert” session

Vaccine Virtual Days guiding lines

Stay tuned for Vaccine Virtual Days 2023

Let science guide the way

Material supplied by the above-country business unit to LOCs for localisation must be subject to local Medical and/or Regulatory review and approval prior to use and/or external distribution.

LOCs to insert local adverse events reporting procedure.

© 2022 GSK group of companies or its licensor. GlaxoSmithKline Biologicals SA. Rixensart, Belgium.

NX-GBL-GVX-WCNT-220011 | June 2022